Literature DB >> 16633129

Colonic health: fermentation and short chain fatty acids.

Julia M W Wong1, Russell de Souza, Cyril W C Kendall, Azadeh Emam, David J A Jenkins.   

Abstract

Interest has been recently rekindled in short chain fatty acids (SCFAs) with the emergence of prebiotics and probiotics aimed at improving colonic and systemic health. Dietary carbohydrates, specifically resistant starches and dietary fiber, are substrates for fermentation that produce SCFAs, primarily acetate, propionate, and butyrate, as end products. The rate and amount of SCFA production depends on the species and amounts of microflora present in the colon, the substrate source and gut transit time. SCFAs are readily absorbed. Butyrate is the major energy source for colonocytes. Propionate is largely taken up by the liver. Acetate enters the peripheral circulation to be metabolized by peripheral tissues. Specific SCFA may reduce the risk of developing gastrointestinal disorders, cancer, and cardiovascular disease. Acetate is the principal SCFA in the colon, and after absorption it has been shown to increase cholesterol synthesis. However, propionate, a gluconeogenerator, has been shown to inhibit cholesterol synthesis. Therefore, substrates that can decrease the acetate: propionate ratio may reduce serum lipids and possibly cardiovascular disease risk. Butyrate has been studied for its role in nourishing the colonic mucosa and in the prevention of cancer of the colon, by promoting cell differentiation, cell-cycle arrest and apoptosis of transformed colonocytes; inhibiting the enzyme histone deacetylase and decreasing the transformation of primary to secondary bile acids as a result of colonic acidification. Therefore, a greater increase in SCFA production and potentially a greater delivery of SCFA, specifically butyrate, to the distal colon may result in a protective effect. Butyrate irrigation (enema) has also been suggested in the treatment of colitis. More human studies are now needed, especially, given the diverse nature of carbohydrate substrates and the SCFA patterns resulting from their fermentation. Short-term and long-term human studies are particularly required on SCFAs in relation to markers of cancer risk. These studies will be key to the success of dietary recommendations to maximize colonic disease prevention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633129     DOI: 10.1097/00004836-200603000-00015

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  672 in total

1.  Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice.

Authors:  Yin Zhu; Cong He; Xueyang Li; Yan Cai; Jinxiang Hu; Yuanhang Liao; Jianhua Zhao; Liang Xia; Wenhua He; Linmeng Liu; Chun Luo; Xu Shu; Qiang Cai; Youxiang Chen; Nonghua Lu
Journal:  J Gastroenterol       Date:  2018-12-05       Impact factor: 7.527

2.  Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells.

Authors:  Tengfei Liu; Jing Li; Yuxin Liu; Nan Xiao; Haitao Suo; Kun Xie; Chunliu Yang; Chen Wu
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

3.  Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells.

Authors:  Jacinta Serpa; Francisco Caiado; Tânia Carvalho; Cheila Torre; Luís G Gonçalves; Cristina Casalou; Pedro Lamosa; Margarida Rodrigues; Zhenping Zhu; Eric W F Lam; Sérgio Dias
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

4.  Shifting from a gene-centric to metabolite-centric strategy to determine the core gut microbiome.

Authors:  Julian R Marchesi
Journal:  Bioeng Bugs       Date:  2011-11-01

Review 5.  Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms.

Authors:  Zahra Nochi; Rikke Katrine Jentoft Olsen; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2017-05-17       Impact factor: 4.982

6.  A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids.

Authors:  Mark A Underwood; Nita H Salzman; Stephen H Bennett; Melissa Barman; David A Mills; Angela Marcobal; Daniel J Tancredi; Charles L Bevins; Michael P Sherman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

7.  Mucin Cross-Feeding of Infant Bifidobacteria and Eubacterium hallii.

Authors:  Vera Bunesova; Christophe Lacroix; Clarissa Schwab
Journal:  Microb Ecol       Date:  2017-07-18       Impact factor: 4.552

8.  Effect of Whole-Grain Barley on the Human Fecal Microbiota and Metabolome.

Authors:  Maria De Angelis; Eustacchio Montemurno; Lucia Vannini; Carmela Cosola; Noemi Cavallo; Giorgia Gozzi; Valentina Maranzano; Raffaella Di Cagno; Marco Gobbetti; Loreto Gesualdo
Journal:  Appl Environ Microbiol       Date:  2015-09-18       Impact factor: 4.792

9.  Antibiotics-mediated intestinal microbiome perturbation aggravates tacrolimus-induced glucose disorders in mice.

Authors:  Yuqiu Han; Xiangyang Jiang; Qi Ling; Li Wu; Pin Wu; Ruiqi Tang; Xiaowei Xu; Meifang Yang; Lijiang Zhang; Weiwei Zhu; Baohong Wang; Lanjuan Li
Journal:  Front Med       Date:  2019-05-02       Impact factor: 4.592

10.  Diversity and Succession of Microbiota during Fermentation of the Traditional Indian Food Idli.

Authors:  Madhvi H Mandhania; Dhiraj Paul; Mangesh V Suryavanshi; Lokesh Sharma; Somak Chowdhury; Sonal S Diwanay; Sham S Diwanay; Yogesh S Shouche; Milind S Patole
Journal:  Appl Environ Microbiol       Date:  2019-06-17       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.